A detailed history of Enterprise Trust & Investment CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Enterprise Trust & Investment CO holds 194 shares of BMY stock, worth $7,771. This represents 0.01% of its overall portfolio holdings.

Number of Shares
194
Holding current value
$7,771
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$72.62 - $79.98 $14,088 - $15,516
194 New
194 $15,000
Q1 2020

Apr 06, 2020

SELL
$46.4 - $67.43 $870,000 - $1.26 Million
-18,750 Closed
0 $0
Q4 2019

Jan 07, 2020

BUY
$49.21 - $64.19 $922,687 - $1.2 Million
18,750 New
18,750 $1.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85.2B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Enterprise Trust & Investment CO Portfolio

Follow Enterprise Trust & Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Trust & Investment CO with notifications on news.